The Latest Breakthroughs in Immunotherapy for Acute Myeloid Leukemia, with a Special Focus on NKG2D Ligands

Acute myeloid leukemia (AML) is a hematological malignancy characterized by clonal expansion of stem and myeloid progenitor cells. Immunotherapy has revolutionized the care for other cancers such as solid tumors and lymphomas, and has the potential to effectively treat AML. There has been substantia...

Descripción completa

Detalles Bibliográficos
Autores principales: Maurer, Stefanie, Zhong, Xiaoxuan, Prada, Betsy Deza, Mascarenhas, John, de Andrade, Lucas Ferrari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784434/
https://www.ncbi.nlm.nih.gov/pubmed/36555547
http://dx.doi.org/10.3390/ijms232415907

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784434/
https://www.ncbi.nlm.nih.gov/pubmed/36555547
http://dx.doi.org/10.3390/ijms232415907

Ejemplares similares